The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Squalene Synthase, a Determinant of Raft-associated Cholesterol and Modulator of Cancer Cell Proliferation
Open accessAbstract
Several cues for cell proliferation, migration, and survival are transmitted through lipid rafts, membrane microdomains enriched in sphingolipids and cholesterol. Cells obtain cholesterol from the circulation but can also synthesize cholesterol de novo through the mevalonate/isoprenoid pathway. This pathway, however, has several branches and also produces non-sterol isoprenoids. Squalene synthase (SQS) is the enzyme that determines the switch toward sterol biosynthesis. Here we demonstrate that in prostate cancer cells SQS expression is enhanced by androgens, channeling intermediates of the mevalonate/isoprenoid pathway toward cholesterol synthesis. Interestingly, the resulting increase in de novo synthesis of cholesterol mainly affects the cholesterol content of lipid rafts, while leaving non-raft cholesterol levels unaffected. Conversely, RNA interference-mediated SQS inhibition results in a decrease of raft-associated cholesterol. These data show that SQS activity and de novo cholesterol synthesis are determinants of membrane microdomain-associated cholesterol in cancer cells. Remarkably, SQS knock down also attenuates proliferation and induces death of prostate cancer cells. Similar effects are observed when cancer cells are treated with the chemical SQS inhibitor zaragozic acid A. Importantly, although the anti-tumor effect of statins has previously been attributed to inhibition of protein isoprenylation, the present study shows that specific inhibition of the cholesterol biosynthesis branch of the mevalonate/isoprenoid pathway also induces cancer cell death. These findings significantly underscore the importance of de novo cholesterol synthesis for cancer cell biology and suggest that SQS is a potential novel target for antineoplastic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The encoded protein is the first enzyme in cholesterol biosynthesis and catalyzes the dimerization of two molecules of farnesyl diphosphate via a two-step reaction to form squalene32, which plays an important role in cholesterol biosynthesis33,34.”
From RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression (2020) · cites this paper as [32]
In the citing paper
“Farnesyl-diphosphate farnesyltransferase 1 (FDFT1) encodes a membrane-associated enzyme acting at a branch point in the mevalonate pathway.”
From RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression (2020) · cites this paper as [32]
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Membrane lipid composition and cellular function.
Spector, A. A., & Yorek, M. A. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34276-0 · Cited by 1,495
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246
Demierre, M., Higgins, P., Gruber, S. B., Hawk, E. T., & Lippman, S. M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1751 · Cited by 833
Lipid rafts: contentious only from simplistic standpoints
Hancock, J. F. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1925 · Cited by 788
Flagged first, then by citations
Research works printed but not linked: 5
- Brown, 1973, Fed. Proc., 32, 2168
- Haeffner, 1984, Cancer Res., 44, 2668
- Marcelli, 1998, Cancer Res., 58, 76
- Swinnen, 1997, Cancer Res., 57, 1086
- De Schrijver, 2003, Cancer Res., 63, 3799
Cited by
Sorted by citations
Lipid metabolic reprogramming in cancer cells
Beloribi‐Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,418
ATP-Citrate Lyase: A Key Player in Cancer Metabolism
Zaidi, N., Swinnen, J. V., & Smans, K. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4112 · Cited by 573
Self-citationLipid metabolism in cancer cells under metabolic stress
Munir, R., Lisec, J., Swinnen, J. V., & Zaidi, N. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0451-4 · Cited by 382
Self-citationMitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma
Montero, J., Morales, A., Llacuna, L., Lluis, J. M., Terrones, O., Basáñez, G., Antonsson, B. E., Prìeto, J., García‐Ruiz, C., Colell, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6161 · Cited by 283
Fessler, M. B., & Parks, J. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100253 · Cited by 274
Weng, M.-L., Chen, W.-K., Chen, X.-Y., Lu, H., Sun, Z.-R., Yu, Q., Sun, P.-F., Xu, Y.-J., Zhu, M.-M., Jiang, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15795-8 · Cited by 242
RetractedPommier, A., Alves, G., Viennois, É., Bernard, S., Communal, Y., Sion, B., Marceau, G., Damon‐Soubeyrand, C., Mouzat, K., Caira, F., et al. (2010) · Oncogene · doi:10.1038/onc.2010.30 · Cited by 228
Anticancer Activity of the Cholesterol Exporter ABCA1 Gene
Smith, B., & Land, H. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.011 · Cited by 208
Antalis, C. J., Arnold, T. S., Rasool, T., Lee, B., Buhman, K. K., & Siddiqui, R. A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0594-8 · Cited by 169
Ahmed, N., Escalona, R. M., Leung, D. T. H., Chan, E., & Kannourakis, G. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.10.002 · Cited by 166
Mitochondria, cholesterol and cancer cell metabolism
Ribas, V., García‐Ruiz, C., & Fernández-Checa, J. C. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0106-5 · Cited by 166
Reconstruction of Tissue-Specific Metabolic Networks Using CORDA
Schultz, A., & Qutub, A. A. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004808 · Cited by 140
Genome‐wide analysis of DNA copy number alterations and gene expression in gastric cancer
Tsukamoto, Y., Uchida, T., Karnan, S., Noguchi, T., Nguyen, L., Tanigawa, M., Takeuchi, I., Matsuura, K., Hijiya, N., Nakada, C., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2424 · Cited by 129
Giacomini, I., Gianfanti, F., Desbats, M. A., Orso, G., Berretta, M., Prayer‐Galetti, T., Ragazzi, E., & Cocetta, V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682911 · Cited by 121
Daniëls, V. W., Smans, K. A., Royaux, I. E., Chypre, M., Swinnen, J. V., & Zaidi, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106913 · Cited by 119
Self-citationZaidi, N., Royaux, I. E., Swinnen, J. V., & Smans, K. A. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0095 · Cited by 118
Self-citationMitochondrial cholesterol in health and disease.
García‐Ruiz, C., Marí, M., Colell, A., Morales, A., Caballero, F. G., Montero, J., Terrones, O., Basáñez, G., & Fernández-Checa, J. C. (2009) · PubMed · doi:10.14670/hh-24.117 · Cited by 101
Pan, J.-J., Solbiati, J., Ramamoorthy, G., Hillerich, B., Seidel, R. D., III, Cronan, J. E., Almo, S. C., & Poulter, C. D. (2015) · ACS Central Science · doi:10.1021/acscentsci.5b00115 · Cited by 96
Androgens Promote Prostate Cancer Cell Growth through Induction of Autophagy
Shi, Y., Han, J. J., Tennakoon, J. B., Mehta, F. F., Merchant, F. A., Burns, A. R., Howe, M. K., McDonnell, D. P., & Frigo, D. E. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1260 · Cited by 96
Das, B., Antoon, R., Tsuchida, R., Lotfi, S., Morozova, O., Farhat, W. A., Malkin, D. M., Koren, G., Yeger, H., & Baruchel, S. (2008) · Neoplasia · doi:10.1593/neo.08466 · Cited by 90
Yang, Y., Jan, Y., Liu, Y., Yang, C., Su, C., Chang, Y., Lai, T., Chiou, J., Tsai, H., Lu, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201404-0714oc · Cited by 77
Links between cancer metabolism and cisplatin resistance
Cocetta, V., Ragazzi, E., & Montopoli, M. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.01.005 · Cited by 77
Sánchez, J., Dávalos, A., Herrera, E., Giera, M. A., Cano-Tebar, S., de la Peña, G., Lasunción, M. A., & Busto, R. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.05.002 · Cited by 73
Cholesterol and male fertility: What about orphans and adopted?
Maqdasy, S., Baptissart, M., Vega, A., Baron, S., Lobaccaro, J. A., & Volle, D. H. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.011 · Cited by 78
Autefage, H., Gentleman, E., Littmann, E., Hedegaard, M. A. B., von Erlach, T. C., O’Donnell, M., Burden, F. R., Winkler, D. A., & Stevens, M. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419799112 · Cited by 72
Locke, J. A., Guns, E. S. T., Lehman, M., Ettinger, S., Zoubeidi, A., Lubik, A. A., Margiotti, K., Fazli, L., Adomat, H. H., Wasan, K. M., et al. (2009) · The Prostate · doi:10.1002/pros.21057 · Cited by 66
Gupta, V. K., Sharma, N., Kesh, K., Dauer, P., Nomura, A., Giri, B., Dudeja, V., Banerjee, S., Bhattacharya, S. K., Saluja, A. K., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.028 · Cited by 66
Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments
Hà, N. T. T., & Lee, C. H. (2020) · Cells · doi:10.3390/cells9112352 · Cited by 73
Effect of Gut Microbiota on Blood Cholesterol: A Review on Mechanisms
Deng, C., Pan, J., Zhu, H., & Chen, Z. (2023) · Foods · doi:10.3390/foods12234308 · Cited by 70
Tsuchiya, M., Hosaka, M., Moriguchi, T., Zhang, S., Suda, M., Yokota‐Hashimoto, H., Shinozuka, K., & Takeuchi, T. (2010) · Endocrinology · doi:10.1210/en.2010-0623 · Cited by 57
Asperger, H., Stamm, N., Gierke, B., Pawlak, M., Hofmann, U., Zanger, U. M., Marton, A., Katona, R. L., Buhala, A., Vízler, C., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01312-8 · Cited by 56
Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions
Laka, K., Makgoo, L., & Mbita, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.841639 · Cited by 51
Haloperidol Disrupts Lipid Rafts and Impairs Insulin Signaling in SH-SY5Y Cells
Sánchez-Wandelmer, J., Dávalos, A., de la Peña, G., Cano, S., Giera, M., Canfrán-Duque, A., Bracher, F., Martín-Hidalgo, A., Fernández-Hernando, C., Lasunción, M. A., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.051 · Cited by 49
Locke, J. A., Wasan, K. M., Nelson, C. C., Guns, E. S. T., & Leon, C. G. (2007) · The Prostate · doi:10.1002/pros.20674 · Cited by 45
Atypical plasma lipid profile in cancer patients: Cause or consequence?
Munir, R., Usman, H., Hasnain, S., Smans, K. A., Kalbacher, H., & Zaidi, N. (2014) · Biochimie · doi:10.1016/j.biochi.2014.03.010 · Cited by 45
Waugh, M. G., Chu, K. M. E., Clayton, E. L., Minogue, S., & Hsuan, J. J. (2010) · Journal of Lipid Research · doi:10.1194/jlr.d012807 · Cited by 45
Ge, H., Zhao, Y., Shi, X., Tan, Z., Chi, X., He, M., Jiang, G., Ji, L., & Li, H. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.12944 · Cited by 46
Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
Ahmed, N., Greening, D. W., Samardzija, C., Escalona, R. M., Chen, M., Findlay, J. K., & Kannourakis, G. (2016) · Scientific Reports · doi:10.1038/srep30061 · Cited by 44
Yeo, D. S.-Y., Chan, R., Brown, G., Ying, L., Sutejo, R., Aitken, J., Tan, B. H., Wenk, M. R., & Sugrue, R. J. (2009) · Virology · doi:10.1016/j.virol.2008.12.017 · Cited by 48
Ambike, A. A., Rosilio, V., Stella, B., Lepêtre‐Mouelhi, S., & Couvreur, P. (2011) · Langmuir · doi:10.1021/la200002d · Cited by 49
Michalik, M., Soczek, E., Kosińska, M., Rak, M., Wójcik‐Pszczoła, K., Lasota, S., Pierzchalska, M., Czyż, J., & Madeja, Z. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.02.023 · Cited by 42
The role of cholesterol metabolism in tumor therapy, from bench to bed
Xia, W., Wang, H., Zhou, X., Wang, Y., Xue, L., Cao, B., & Song, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.928821 · Cited by 40
Fukuma, Y., Matsui, H., Koike, H., Sekine, Y., Shechter, I., Ohtake, N., Nakata, S., Ito, K., & Suzuki, K. (2012) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.14 · Cited by 39
Self-citationBaruthio, F., Quadroni, M., Rüegg, C., & Mariotti, A. (2008) · PROTEOMICS · doi:10.1002/pmic.200800169 · Cited by 39
Crosstalk between cholesterol metabolism and psoriatic inflammation
Luo, L., Guo, Y., Chen, L., Zhu, J., & Li, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1124786 · Cited by 38
Monoclonal Antibodies Targeting Surface-Exposed and Secreted Proteins from Staphylococci
Speziale, P., & Pietrocola, G. (2021) · Vaccines · doi:10.3390/vaccines9050459 · Cited by 37
Jiang, H., Tang, E., Chen, Y., Liu, H., Zhao, Y., Lin, M., & He, L. (2021) · Cancer Science · doi:10.1111/cas.15248 · Cited by 33
Staedler, D., Chapuis‐Bernasconi, C., Dehmlow, H., Fischer, H., Juillerat‐Jeanneret, L., & Aebi, J. D. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300256z · Cited by 31
Characterization of Farnesyl Diphosphate Farnesyl Transferase 1 ( FDFT1 ) Expression In Cancer
Tüzmen, Ş., Hostetter, G. H., Watanabe, A. T., Ekmekçi, C. G., Carrigan, P. E., Shechter, I., Kallioniemi, O., Miller, L. J., & Mousses, S. (2018) · Personalized Medicine · doi:10.2217/pme-2016-0058 · Cited by 30
Self-citationBanfi, C., Baetta, R., Gianazza, E., & Tremoli, E. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.03.001 · Cited by 31
Paw, M., Wnuk, D., Kądziołka, D., Sęk, A., Lasota, S., Czyż, J., Madeja, Z., & Michalik, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092571 · Cited by 30
Saito, K., Shirasago, Y., Suzuki, T., Aizaki, H., Hanada, K., Wakita, T., Nishijima, M., & Fukasawa, M. (2014) · Journal of Virology · doi:10.1128/jvi.03385-14 · Cited by 29
Shedding light on membrane rafts structure and dynamics in living cells
Nieto‐Garai, J. A., Lorizate, M., & Contreras, F. ‐. (2021) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2021.183813 · Cited by 30
Kanmalar, M., Sani, S. F. A., Kamri, N. I. N. B., Said, N. A. B. M., Jamil, A. H. A., Kuppusamy, S., Mun, K.-S., & Bradley, D. A. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00307-x · Cited by 29
Cancer cell lipid class homeostasis is altered under nutrient-deprivation but stable under hypoxia
Lisec, J., Jaeger, C., Rashid, R., Munir, R., & Zaidi, N. (2019) · BMC Cancer · doi:10.1186/s12885-019-5733-y · Cited by 27
Chen, Y., Chen, X., Luo, G., Zhang, X., Lü, F., Qiao, L., He, W., Li, G., & Zhang, Y. (2018) · Molecules · doi:10.3390/molecules23051040 · Cited by 25
Casado, M. E., Huerta, L., Ortiz, A. I., Pérez-Crespo, M., Gutiérrez‐Adán, A., Kraemer, F. B., Lasunción, M. A., Busto, R., & Martín‐Hidalgo, A. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m028076 · Cited by 24
Mitochondrial Cholesterol and the Paradox in Cell Death
García‐Ruiz, C., Ribas, V., Baulies, A., & Fernández-Checa, J. C. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_110 · Cited by 22
Ohmori, K., Kamei, A., Watanabe, Y., & Abe, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063216 · Cited by 24
Zhang, Y., Li, Y., Wang, R., Wang, S., Sun, B., Cao, D., Sun, Z., Lv, W., Bo, M., & Zhang, Y. (2025) · Antioxidants · doi:10.3390/antiox14080926 · Cited by 20
Use of cholesterol metabolism for anti-cancer strategies
Ediriweera, M. K. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103347 · Cited by 16
Chen, D., Li, G., Luo, L., Liu, K., Chu, X., Liu, K., Lai, T., Liao, Y., Lin, X., & Chen, J. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156155 · Cited by 15
ATP‑binding cassette transporter A1: A promising therapy target for prostate cancer (Review)
Xiong, T., Xu, G., Huang, X., Lu, K., Xie, W., Yin, K., & Tu, J. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1506 · Cited by 15
Sánchez, J., Hernández‐Pinto, A. M., Cano-Tebar, S., Dávalos, A., Peña, G. D. L., Puebla‐Jiménez, L., Arilla, E., Lasunción, M. A., & Busto, R. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06159.x · Cited by 14
Cholesterol depletion decreases adhesion of non-small cell lung cancer cells to E-selectin
Mohammadalipour, A., Showalter, C. A., Muturi, H. T., Farnoud, A. M., Najjar, S. M., & Burdick, M. M. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00197.2020 · Cited by 15
Yamasaki, M., Nishimura, M., Sakakibara, Y., Suiko, M., Morishita, K., & Nishiyama, K. (2014) · Food & Function · doi:10.1039/c4fo00635f · Cited by 13
Reasoning on Scientific Workflows
Lacroix, Z., Legendre, C. R. L., & Tüzmen, Ş. (2009) · IEEE World Congress on Services (SERVICES) · doi:10.1109/services-i.2009.73 · Cited by 14
The Lipogenic Switch in Cancer
Brusselmans, K., & Swinnen, J. V. (2008) · Springer eBooks · doi:10.1007/978-0-387-84835-8_3 · Cited by 14
Self-citationStørvold, G. L., Fleten, K. G., Olsen, C. G., Follestad, T., Krokan, H. E., & Schønberg, S. A. (2009) · Lipids · doi:10.1007/s11745-009-3324-4 · Cited by 12
LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR?
Cariello, M., Ducheix, S., Maqdasy, S., Baron, S., Moschetta, A., & Lobaccaro, J. A. (2018) · Nuclear Receptor Signaling · doi:10.1177/1550762918801070 · Cited by 12
Trenin, A. S. (2013) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162013060095 · Cited by 10
Bu, Y., Chen, S., Ruan, M., Wu, L., Wang, H., Li, N., Zhao, X.-J. G., Yu, X., & Liu, Z. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.02.034 · Cited by 10
Hsu, J., Leu, W., Zhong, N., & Guh, J. (2021) · Molecules · doi:10.3390/molecules26195967 · Cited by 12
Absolute Configuration of Hydroxysqualene. An Intermediate in Bacterial Hopanoid Biosynthesis
Pan, J.-J., Ramamoorthy, G., & Poulter, C. D. (2016) · Organic Letters · doi:10.1021/acs.orglett.5b03546 · Cited by 9
Fu, Y., Miyazaki, K., Chiba, Y., Funada, K., Yuta, T., Tian, T., Mizuta, K., Kawahara, J., Zhang, L., Martı́n, D., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104638 · Cited by 8
Alioui, A., Dufour, J., Leoni, V., Loregger, A., Moeton, M., Iuliano, L., Zerbinati, C., Septier, A., Val, P., Fouache, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00508-5 · Cited by 8
RetractedNew applications of squalene synthase inhibitors: Membrane cholesterol as a therapeutic target
Kourounakis, A. P., & Bavavea, E. I. (2020) · Archiv der Pharmazie · doi:10.1002/ardp.202000085 · Cited by 10
Yoneten, K. K., Kasap, M., Arğa, K. Y., Akpınar, G., & Utkan, N. Z. (2021) · Cancer Biomarkers · doi:10.3233/cbm-203093 · Cited by 7
Targeting NPC1 in Renal Cell Carcinoma
Fazliyeva, R., Makhov, P. B., Uzzo, R. G., & Kolenko, V. M. (2024) · Cancers · doi:10.3390/cancers16030517 · Cited by 8
Klas, K., Copic, D., Direder, M., Laggner, M., Prucksamas, P. S., Грубер, Ф., Ankersmit, H. J., & Mildner, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111631 · Cited by 8
Inhomogeneities in sodium decylsulfate doped 1,2-dipalmitoylphosphatidylcholine bilayer
Ortona, O., Vitagliano, V. M., Fessas, D., Vecchio, P. D., & D’Errico, G. (2009) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2009.11.054 · Cited by 7
Mavridi, D., Katavati, T., & Kourounakis, A. P. (2025) · Medicinal Research Reviews · doi:10.1002/med.70012 · Cited by 7
Al-Sawahli, M. M., El-Feky, Y. A., Mohammed, A. J., Mohamed, N. M., El‐Telbany, R. F. A., Alamri, Z. Z., Melebary, S. J., Alfaifi, M. Y., Elbehairi, S. E. I., Noreddin, A. M., et al. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2481823 · Cited by 4
Inferring past demography and genetic adaptation in Spain using the GCAT cohort
Garcia-Calleja, J., Biagini, S. A., de Cid, R., Calafell, F., & Bosch, E. (2025) · Scientific Reports · doi:10.1038/s41598-025-98272-w · Cited by 5
Effects of Fdft 1 gene silencing and VD3 intervention on lung injury in hypoxia-stressed rats
Pu, X., Lin, X., Qi, Y., Li, Y., Li, T., Liu, Y., & Wei, D. (2022) · Genes & Genomics · doi:10.1007/s13258-022-01284-3 · Cited by 4
Dong, X., Dai, H., Yao, L., Lin, Y., Wang, Y., Li, Y., Zhang, X., Zhou, L., Lu, J., & Yin, W. (2025) · Oncogene · doi:10.1038/s41388-025-03545-3 · Cited by 3
Hosseinpour, M. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/18149.8187 · Cited by 3
Li, N., Wang, G., Guo, M., Zhu, N., & Yu, W. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150046 · Cited by 2
Regulation of Lipid Metabolism Under Stress and Its Role in Cancer
Munir, R., & Zaidi, N. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_3 · Cited by 3
Zhang, S., Liu, J., Yang, Y., Tao, R., Ren, X., Zhou, X., & Liu, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1540667 · Cited by 2
Riz, I. (2013) · Journal of Bone Marrow Research · doi:10.4172/2329-8820.1000105 · Cited by 2
Cancer Cell Metabolism Featuring Nrf2
Chatterjee, P., Yadav, M., Chauhan, N., Huang, Y. S., & Luo, Y. (2018) · Current Drug Discovery Technologies · doi:10.2174/1570163815666180911092443 · Cited by 2
Cholesterol metabolism in prostate cancer
Koltai, T., Reshkin, S. J., Baltazar, F., & Fliegel, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90528-2.00007-2 · Cited by 2
Contigli, C., Valle, M. S., Oloris, S. C. S., Pimenta, L. P. S., & Takahashi, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-18587-8_17 · Cited by 2
Kanmalar, M., Kamal, R., Sani, S. F. A., Pathmanathan, D., Said, N. A. B. M., Paramanantham, Y., Jamil, A. H. A., Mun, K.-S., Kuppusamy, S., Almugren, K. S., et al. (2024) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2024.111372 · Cited by 2
Klas, K., Copic, D., Direder, M., Laggner, M., Prucksamas, P. S., Грубер, Ф., Ankersmit, H. J., & Mildner, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.07.463171 · Cited by 2
Androgens and the Lipogenic Switch in Prostate Cancer
Swinnen, J. V., Brusselmans, K., Heemers, H. V., & Verhoeven, G. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_31 · Cited by 1
Self-citationKatavati, T., Chatzipieris, F. P., Magkrioti, C., Stylianaki, E.-A., Aerakis, E., Grammenoudi, S., Tsoumakidou, M., Aidinis, V., Matralis, A. N., & Kourounakis, A. P. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00458 · Cited by 1
Aberrant de novo cholesterogenesis: Clinical significance and implications
Rashid, R., Ameer, F., Kalbacher, H., Scandiuzzi, L., & Zaidi, N. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.09.014 · Cited by 1
Alioui, A., Dufour, J., Leoni, V., Loregger, A., Moeton, M., Iuliano, L., Zerbinati, C., Septier, A., Val, P., Fouache, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04653-3 · Cited by 1
Retracted
Metadata
- Authors
- Brusselmans, K., Timmermans, L., Van de Sande, T., Van Veldhoven, P. P., Guan, G., Shechter, I., Claessens, F., Verhoeven, G., & Swinnen, J. V.
- Affiliations
- KU Leuven (BE)
- Uniformed Services University of the Health Sciences (US)
- Corresponding author
- Swinnen, Johannes V.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 282
- Issue
- 26
- Pages
- 18777-18785
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2136706193
- Cited by
- 116
- References
- 49
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 4 · 2016: 7 · 2015: 3 · 2014: 5 · 2013: 4 · 2012: 8
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Keywords
- squalene synthase, cholesterol biosynthesis, lipid rafts, prostate cancer, androgens, tumor cell proliferation, cancer cell death, statins, zaragozic acid A, sterol biosynthesis
- MeSH terms
- Acetates, Androgens, Carbon Radioisotopes, Cell Division, Cholesterol, Detergents, Enzyme Inhibitors, Humans, Male, Promoter Regions, Genetic, Prostatic Neoplasms, RNA, Messenger, Farnesyl-Diphosphate Farnesyltransferase, Terpenes, Tricarboxylic Acids, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Cell Death, Bridged Bicyclo Compounds, Heterocyclic, Membrane Microdomains, RNA, Small Interfering, Cell Line, Tumor, Sterol Regulatory Element Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review